<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02631837</url>
  </required_header>
  <id_info>
    <org_study_id>B689201526261</org_study_id>
    <nct_id>NCT02631837</nct_id>
  </id_info>
  <brief_title>Hysterectomy by Transabdominal Laparoscopy or NOTES</brief_title>
  <acronym>HALON</acronym>
  <official_title>Hysterectomy for Benign Gynaecological Disease by Natural Orifice Transluminal Endoscopic Surgery or Laparoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Imelda Hospital, Bonheiden</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Imelda Hospital, Bonheiden</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: To randomly compare hysterectomy by vaginal Natural Orifice Transluminal
      Endoscopic Surgery (vNOTES) versus laparoscopy uterus in women with benign gynecological
      pathology.

      Study design: Randomized controlled/single
      center/single-blinded/parallel-group/non-inferiority/efficacy trial.

      Study population: All women aged 18 to 70 years regardless of parity with a non-prolapsed
      uterus and a benign indication for hysterectomy.

      Primary study outcome parameters: successful removal of the uterus by the intended technique.

      Secondary outcomes: the proportion of women admitted to the in-hospital ward; postoperative
      pain scores; the total amount of analgesics used; postoperative infection; per- or
      postoperative complications; hospital readmission rates; duration of the surgical procedure;
      incidence and intensity of dyspareunia; sexual wellbeing; health-related quality of life;
      costs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      l1.Objectives of the HALON Trial The primary research questions of this IDEAL stage 2b
      efficacy trial are as follows: is a vNOTES (vaginal Natural Orifice Transluminal Endoscopic
      Surgery) hysterectomy at least as effective compared to the standard transabdominal
      laparoscopic approach (LSC) for removing a non-prolapsed uterus without the need for
      conversion to an alternative approach? (non inferiority design)

      Secondary research questions are:

        -  Do more women treated by vNOTES prefer to leave the day care unit on the day of surgery
           compared to LSC?

        -  Do women treated by vNOTES suffer from less pain compared to women treated by LSC in the
           first postoperative week?

        -  Is the removal of a uterus by vNOTES faster compared to LSC?

        -  Does a vNOTES cause more pelvic infection or other complications compared to LSC?

        -  Does a vNOTES result in more hospital readmissions within 6 weeks after surgery compared
           to LSC?

        -  Does a vNOTES approach result in more women reporting dyspareunia, less sexual wellbeing
           or less health-related quality of life at 3 or 6 months after surgery when compared to
           women treated by LSC?

        -  What are the direct and indirect costs up to 6 weeks after the surgical intervention of
           a vNOTES compared to LSC? 2. TRIAL DESIGN 2.1. Design A single center, single-blinded,
           parallel group randomized, non-inferiority efficacy trial.

      2.2. Simple pilot randomized trial. 2.3. Time schedule Based upon the mean number of
      hysterectomies performed annually for benign gynecological disease at the department of
      Obstetrics and Gynecology of the participating center (168) the investigators estimate that
      the duration of recruitment will be 12 months. Based upon the follow up (6 months) and the
      period of analysis/reporting (3 months) the total study period will be 2 years.

      2.4. Participating center Department of Obstetrics and Gynecology Imeldahospital Imeldalaan 9
      2820 Bonheiden Belgium 3. ELIGIBILITY, CONSENT AND RANDOMIZATION 3.1. Screening and consent
      prior to surgery All women aged 18 to 70 years, regardless of parity, with a non-prolapsed
      uterus in need of a hysterectomy for benign indication are eligible for inclusion.

      3.2. Determining eligibility All women aged 18 to 70 years, regardless of parity, with a
      non-prolapsed uterus in need of a hysterectomy for benign indication who provide consent to
      participation are eligible in the HALON trial and will be randomized before the procedure.

      3.3. Randomization If the woman is eligible for the HALON trial, the trial secretary will
      obtain a randomized allocation the day before surgery. This will be done using a
      randomization list generated by a free computer software program offered by Research
      Randomizer (https://www.randomizer.org). The random sequence generation will be concealed
      using sequentially numbered opaque sealed envelopes. The envelope will be opened by the nurse
      assistant the day before surgery for practical logistic reasons.

      3.4. Patients with strong preference for treatment A minority of women will express a clear
      preference for one of both treatments (e.g. strong desire to have no scar) and for this
      reason will not wish to be randomized between surgical treatments. To investigate how
      outcomes vary by choice, these women could be followed up in exactly the same way as for
      those women randomized into the HALON trial. A formal non-randomized follow-up of these women
      will not be done for logistical reasons.

      3.5. Stratification of randomization A blocked randomization procedure will be used to avoid
      chance imbalances for the parameter 'uterine size'.

      4. TREATMENT ALLOCATIONS 4.1. Surgical procedures The principal investigator, who has
      training and experience in both laparoscopy and NOTES, will perform all surgical procedures.
      He is therefore not blinded. All vNOTES participants will be blinded by three superficial
      non-therapeutic or &quot;mock&quot; skin incisions similar to those done with the laparoscopic
      technique.

      4.1.1 vNOTES hysterectomy This is the surgical procedure done in the intervention arm of the
      HALON trial. 4.1.2 LSC hysterectomy This is the surgical procedure done in the control arm of
      the HALON trial. 5. FOLLOW-UP AND OUTCOME MEASURES 5.1. Clinical assessments 5.1.1 Format
      PROMs (Patient reported outcomes) will be collected using a postal questionnaire, which will
      include a combination of disease specific (Pain on sexual intercourse measured by VAS scale
      and SSFS Scale) and generic measurement instruments (EQ-5D).

      The postal questionnaires will be sent from the HALON Trial Office with postage paid
      envelopes two weeks before the due date. Reminders will be sent to patients if the
      questionnaire is not returned within one week of the due date and attempts will be made to
      contact the patient by phone if the questionnaire is not returned by two weeks after the due
      date.

      5.1.2 Timing of assessments The primary outcome will be measured clinically at the end of the
      surgical procedure. In addition PROMs will take place at baseline (pain on sexual
      intercourse, health-related quality of life and sexual well being), the evening of the
      surgical intervention (in-hospital admission), during the first postoperative week (pain by
      VAS scores and analgetic drugs) and at 3 and 6 months (dyspareunia/ sexual well being/health
      related quality of life). Clinical physician assessment will take place the evening of the
      surgical intervention (in-hospital admission) and during the first six weeks following
      surgery (pelvic infection, surgical complications, hospital readmission rate).

      5.2. Primary clinical outcome measure The proportion of women successfully treated by
      removing the uterus by the intended approach without conversion to another approach, using a
      dichotomous outcome measure, will be used as a measure of efficacy.

      5.3. Secondary clinical outcome measures

      The following secondary outcomes will be measured:

        -  The proportion of women addmitted in-hospital for at least one night observation based
           on their own preference, as a dichotomous outcome.

        -  Postoperative pain scores, as an ordinal outcome, measured using a Visual Analogue Scale
           (VAS) twice daily from day 1 till 7 self-reported by the participating women. The VAS
           scores range from 0= no pain to 10= worst imaginable pain.

        -  Postoperative pain defined by the total amount of analgesics used as described in the
           standardized pain treatment protocol, as a continuous outcome.

        -  Postoperative infection as a dichotomous outcome.

        -  Per- or postoperative complications according to the Clavien- Dindo classification
           detected during the first six weeks of surgery, as a dichotomous outcome.

        -  The number of women readmitted to hospital within 6 weeks following surgery.

        -  Incidence and intensity of dyspareunia recorded by the participants at baseline, 3 and 6
           months by self-reporting using a simple questionnaire and a Visual Analogue Scale (VAS)
           scale, as a dichotomous and ordinal outcome. The VAS scores range from 0= no pain to 10=
           worst imaginable pain.

        -  Sexual wellbeing at baseline, at 3 and 6 months by self-reporting the Short Sexual
           Functioning Scale (SSFS). The SSFS is a questionnaire with 7 multiple choice open ended
           questions.

        -  Health related quality of life, at baseline, at 3 and 6 months by self-reporting the
           EQ-5D-3L scale. The EQ-5D-3L scale is a questionnaire on 5 domains with 3 open ended
           questions and a scale from 0= worst possible health-related quality of life to 100= best
           possible health-related quality of life.

        -  Duration of surgery measured as the time in minutes from the insertion of the bladder
           catheter to the end of vaginal/abdominal wound closure, as a continuous outcome. 5.4.The
           direct and indirect costs up to 6 weeks after the hysterectomy of the vNOTES technique
           compared to LSC.

           6. ACCRUAL AND ANALYSIS 6.1. Sample size The sample size for the primary outcome of this
           trial has been chosen to give good statistical power to preclude any clinically
           important inferiority of vNOTES compared to laparoscopy and is based on evidence
           retrieved from a Dutch prospective cohort study. Based on the power calculations for the
           primary outcome and assuming a loss-to-follow-up rate of 15% we decided to include 66
           study participants in the HALON trial.

      6.2. Projected accrual and attrition rates Based upon the mean number of hysterectomies
      performed annually at the department of Obstetrics and Gynecology of the participating center
      (168) the investigators anticipate that the duration of recruitment will be 12 months. Based
      upon the follow up (6 months) and the period of analysis/reporting (3 months) the total study
      period will be 2 years. First publication will be possible within four years of trial
      commencement.

      The sample size calculations have allowed for a 15% loss to follow up rate. In order to
      minimize rates of attrition a dedicated research secretary will be employed to optimize
      recruitment and follow up.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 2015</start_date>
  <completion_date type="Actual">July 15, 2017</completion_date>
  <primary_completion_date type="Actual">February 24, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Successful Removal of the Uterus Without Conversion to Another Technique</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Successful removal of the uterus without conversion to another technique with or without morcellation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Admission in Hospital for at Least One Night Observation</measure>
    <time_frame>Measured on the day of the surgical intervention</time_frame>
    <description>The number of women admitted in-hospital for at least one night observation based on their own preference after discharge from the day care unit, as a dichotomous outcome. The decision to discharge or to admit to hospital for the night will be based solely on the choice of the woman to return home the same day or stay overnight.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Pain Scores</measure>
    <time_frame>The first seven days after the surgical intervention</time_frame>
    <description>Postoperative pain scores, as an ordinal outcome, measured using a Visual Analogue Scale (VAS) twice daily (morning and evening) from day 1 till 7 selfreported by the participating women. VAS scores from 0 to 10 with 0 = no pain and 10= worst pain ever imaginable.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Use of Analgetic Drugs for Postoperative Pain</measure>
    <time_frame>The first week after the surgical intervention</time_frame>
    <description>Postoperative pain defined by the total amount of analgesics used as described in the standardized pain treatment protocol, as a continuous outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Infection</measure>
    <time_frame>The first six weeks after the surgical intervention</time_frame>
    <description>Postoperative infection defined by lower abdominal pain with fever &gt; 38°C and positive clinical signs or laboratory findings, detected during the first six weeks of surgery, as a dichotomous outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intra- Operative Complications</measure>
    <time_frame>At the time of the surgical intervention</time_frame>
    <description>Intra- operative complications according to the Clavien- Dindo classification detected during the first six weeks of surgery, as a dichotomous outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative Complications</measure>
    <time_frame>The first six weeks after the surgical intervention</time_frame>
    <description>Postoperative complications detected during the first six weeks of surgery, as a dichotomous outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Readmission</measure>
    <time_frame>The first six weeks after the surgical intervention</time_frame>
    <description>The number of women readmitted to hospital within six weeks following surgery, as a dichotomous outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of the Surgical Intervention</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Duration of surgery measured as the time in minutes from the insertion of the bladder catheter to the end of vaginal/ abdominal wound closure, as a continuous outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vaginal Pain During Sexual Intercourse at Three Months</measure>
    <time_frame>At 3 months after the surgical intervention</time_frame>
    <description>Incidence of vaginal dyspareunia recorded by the participants at 3 months by self-reporting using a simple questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vaginal Pain During Sexual Intercourse at Six Months</measure>
    <time_frame>At 6 months after the surgical intervention</time_frame>
    <description>Incidence of vaginal dyspareunia recorded by the participants at 6 months by self-reporting using a simple questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvic Pain During Sexual Intercourse at Three Months</measure>
    <time_frame>At 3 months after the surgical intervention</time_frame>
    <description>Incidence of pelvic dyspareunia recorded by the participants at 3 months by self-reporting using a simple questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pelvic Pain During Sexual Intercourse at Six Months</measure>
    <time_frame>At 6 months after the surgical intervention</time_frame>
    <description>Incidence of pelvic dyspareunia recorded by the participants at 6 months by self-reporting using a simple questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related Quality of Life at Three Months</measure>
    <time_frame>At 3 months after the surgical intervention</time_frame>
    <description>Health-related quality of life at 3 months by self-reporting the EQ-5D scale.The reported values for the health-related quality of life are self-reported values using the VAS part of the two part EQ-5D-3L questionnaire. The scale ranges from 0 (worst quality) to 100 (best quality).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health-related Quality of Life at Six Months</measure>
    <time_frame>At 6 months after the surgical intervention</time_frame>
    <description>Health-related quality of life at 6 months by self-reporting the EQ-5D scale. The reported values for the health-related quality of life are self-reported values using the VAS part of the two part EQ-5D-3L questionnaire. The scale ranges from 0 (worst quality) to 100 (best quality).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Sexual Well Being</measure>
    <time_frame>At baseline, 3 months and 6 months after the surgical intervention</time_frame>
    <description>Sexual wellbeing at baseline, at 3 and 6 months by self-reporting using the SSFS (Short Sexual Function Scale). The SSFS is a questionnaire of 7 open ended questions on sexual wellbeing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Direct Costs</measure>
    <time_frame>Up to 6 weeks postoperative</time_frame>
    <description>Calculating the comparative direct costs in USD of both techniques up to 6 weeks after the surgical intervention</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Uterine Diseases</condition>
  <arm_group>
    <arm_group_label>vNOTES hysterectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>vaginal Natural Orifice Transluminal Endoscopic Surgery</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LSC hysterectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Laparoscopic hysterectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>vNOTES hysterectomy</intervention_name>
    <description>Surgical removal of the uterus by Natural Orifice Transluminal Endoscopic Surgery using a colpotomy</description>
    <arm_group_label>vNOTES hysterectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>LSC hysterectomy</intervention_name>
    <description>Surgical removal of the uterus by transabdominal laparoscopy</description>
    <arm_group_label>LSC hysterectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All women aged 18 to 70 years regardless of parity, with a non-prolapsed uterus in
             need of a hysterectomy for benign indication

          -  Written informed consent obtained prior to surgery

        Exclusion Criteria:

          -  History of rectal surgery

          -  Suspected rectovaginal endometriosis

          -  Suspected malignancy

          -  History of pelvic inflammatory disease, especially prior tubo-ovarian or pouch of
             Douglas abscess

          -  Active lower genital tract infection e.g. Chlamydia, N. gonorrhoeae

          -  Virgo

          -  Pregnancy

          -  Failure to provide written informed consent prior to surgery
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jan Baekelandt, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Imelda Hospital, Bonheiden</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Imelda Hospital</name>
      <address>
        <city>Bonheiden</city>
        <state>Antwerp</state>
        <zip>2820</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Reynders A, Baekelandt J. Adnexectomy by Poor Man's Transvaginal NOTES. Gynecol Surg 2015; 12: 207-11</citation>
  </reference>
  <reference>
    <citation>Van Peer S, Baekelandt J. Natural orifice transluminal endoscopic surgery (NOTES) salpingectomy for ectopic pregnancy: a first series demonstrating how a new surgical technique can be applied in a low-resource setting. Gynecol Surg 2015; 12: 299-302</citation>
  </reference>
  <reference>
    <citation>Baekelandt J, De Mulder PA, Le Roy I, Mathieu C, Laenen A, Enzlin P, Weyers S, Mol BW, Bosteels JJ. HALON-hysterectomy by transabdominal laparoscopy or natural orifice transluminal endoscopic surgery: a randomised controlled trial (study protocol). BMJ Open. 2016 Aug 12;6(8):e011546. doi: 10.1136/bmjopen-2016-011546.</citation>
    <PMID>27519922</PMID>
  </reference>
  <reference>
    <citation>Baekelandt JF, De Mulder PA, Le Roy I, Mathieu C, Laenen A, Enzlin P, Weyers S, Mol B, Bosteels J. Hysterectomy by transvaginal natural orifice transluminal endoscopic surgery versus laparoscopy as a day-care procedure: a randomised controlled trial. BJOG. 2019 Jan;126(1):105-113. doi: 10.1111/1471-0528.15504.</citation>
    <PMID>30325565</PMID>
  </reference>
  <results_reference>
    <citation>Su H, Yen CF, Wu KY, Han CM, Lee CL. Hysterectomy via transvaginal natural orifice transluminal endoscopic surgery (NOTES): feasibility of an innovative approach. Taiwan J Obstet Gynecol. 2012 Jun;51(2):217-21. doi: 10.1016/j.tjog.2012.04.009.</citation>
    <PMID>22795097</PMID>
  </results_reference>
  <results_reference>
    <citation>Lee CL, Wu KY, Su H, Wu PJ, Han CM, Yen CF. Hysterectomy by transvaginal natural orifice transluminal endoscopic surgery (NOTES): a series of 137 patients. J Minim Invasive Gynecol. 2014 Sep-Oct;21(5):818-24. doi: 10.1016/j.jmig.2014.03.011. Epub 2014 Mar 25.</citation>
    <PMID>24681063</PMID>
  </results_reference>
  <results_reference>
    <citation>Atallah S, Martin-Perez B, Albert M, Schoonyoung H, Quinteros F, Hunter L, Larach S. Vaginal Access Minimally Invasive Surgery (VAMIS): A New Approach to Hysterectomy. Surg Innov. 2015 Aug;22(4):344-7. doi: 10.1177/1553350614560273. Epub 2014 Nov 27.</citation>
    <PMID>25432882</PMID>
  </results_reference>
  <results_reference>
    <citation>Yang YS, Kim SY, Hur MH, Oh KY. Natural orifice transluminal endoscopic surgery-assisted versus single-port laparoscopic-assisted vaginal hysterectomy: a case-matched study. J Minim Invasive Gynecol. 2014 Jul-Aug;21(4):624-31. doi: 10.1016/j.jmig.2014.01.005. Epub 2014 Jan 21.</citation>
    <PMID>24462594</PMID>
  </results_reference>
  <results_reference>
    <citation>Wang CJ, Huang HY, Huang CY, Su H. Hysterectomy via transvaginal natural orifice transluminal endoscopic surgery for nonprolapsed uteri. Surg Endosc. 2015 Jan;29(1):100-7. doi: 10.1007/s00464-014-3639-y. Epub 2014 Oct 1.</citation>
    <PMID>25270610</PMID>
  </results_reference>
  <results_reference>
    <citation>Baekelandt J. Total Vaginal NOTES Hysterectomy: A New Approach to Hysterectomy. J Minim Invasive Gynecol. 2015 Sep-Oct;22(6):1088-94. doi: 10.1016/j.jmig.2015.05.015. Epub 2015 May 22.</citation>
    <PMID>26009278</PMID>
  </results_reference>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>December 9, 2015</study_first_submitted>
  <study_first_submitted_qc>December 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2015</study_first_posted>
  <results_first_submitted>January 21, 2019</results_first_submitted>
  <results_first_submitted_qc>June 9, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">June 11, 2020</results_first_posted>
  <last_update_submitted>June 9, 2020</last_update_submitted>
  <last_update_submitted_qc>June 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Imelda Hospital, Bonheiden</investigator_affiliation>
    <investigator_full_name>Dr Jan Baekelandt, MD</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>NOTES</keyword>
  <keyword>Laparoscopic surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Interim analyses of major endpoints will be supplied, in strict confidence, to an independent Data Monitoring and Ethics Committee (DMEC) along with updates on results of other related studies, and any other analyses that the DMEC may request.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 14, 2016</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/37/NCT02631837/SAP_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>December 28, 2015</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/37/NCT02631837/Prot_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Between December 9, 2015, and February 23, 2017, 194 women were screened for eligibility</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>vNOTES Hysterectomy</title>
          <description>vaginal Natural Orifice Transluminal Endoscopic Surgery
vNOTES hysterectomy: Surgical removal of the uterus by Natural Orifice Transluminal Endoscopic Surgery using a colpotomy</description>
        </group>
        <group group_id="P2">
          <title>LSC Hysterectomy</title>
          <description>Laparoscopic hysterectomy
LSC hysterectomy: Surgical removal of the uterus by transabdominal laparoscopy</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
                <participants group_id="P2" count="35"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="35"/>
                <participants group_id="P2" count="35"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All participants included were women.</population>
      <group_list>
        <group group_id="B1">
          <title>vNOTES Hysterectomy</title>
          <description>vaginal Natural Orifice Transluminal Endoscopic Surgery
vNOTES hysterectomy: Surgical removal of the uterus by Natural Orifice Transluminal Endoscopic Surgery using a colpotomy</description>
        </group>
        <group group_id="B2">
          <title>LSC Hysterectomy</title>
          <description>Laparoscopic hysterectomy
LSC hysterectomy: Surgical removal of the uterus by transabdominal laparoscopy</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="35"/>
            <count group_id="B2" value="35"/>
            <count group_id="B3" value="70"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>Age of the participants in years</description>
          <units>Years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="35"/>
                    <count group_id="B2" value="35"/>
                    <count group_id="B3" value="70"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="46" lower_limit="24" upper_limit="65"/>
                    <measurement group_id="B2" value="49" lower_limit="34" upper_limit="68"/>
                    <measurement group_id="B3" value="47" lower_limit="24" upper_limit="68"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Female</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="35"/>
                    <count group_id="B2" value="35"/>
                    <count group_id="B3" value="70"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Belgium</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="35"/>
                    <count group_id="B2" value="35"/>
                    <count group_id="B3" value="70"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index</title>
          <units>kg/m²</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="35"/>
                    <count group_id="B2" value="35"/>
                    <count group_id="B3" value="70"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26.6" lower_limit="17.7" upper_limit="44.1"/>
                    <measurement group_id="B2" value="26.4" lower_limit="18.6" upper_limit="42.9"/>
                    <measurement group_id="B3" value="26.5" lower_limit="17.7" upper_limit="44.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Number of vaginal births</title>
          <units>number of vaginal births</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="35"/>
                    <count group_id="B2" value="35"/>
                    <count group_id="B3" value="70"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.4" lower_limit="0" upper_limit="4"/>
                    <measurement group_id="B2" value="1.3" lower_limit="0" upper_limit="3"/>
                    <measurement group_id="B3" value="1.4" lower_limit="0" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Prior abdominal surgery</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="35"/>
                    <count group_id="B2" value="35"/>
                    <count group_id="B3" value="70"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Prior Caesarean section</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="35"/>
                    <count group_id="B2" value="35"/>
                    <count group_id="B3" value="70"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Uterine weight</title>
          <units>grams</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="35"/>
                    <count group_id="B2" value="35"/>
                    <count group_id="B3" value="70"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="206.2" lower_limit="44.0" upper_limit="788.0"/>
                    <measurement group_id="B2" value="177.3" lower_limit="28.0" upper_limit="590.0"/>
                    <measurement group_id="B3" value="191.7" lower_limit="28.0" upper_limit="788.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pain vagina sexual intercourse</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="35"/>
                    <count group_id="B2" value="35"/>
                    <count group_id="B3" value="70"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Pain abdomen sexual intercourse</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="35"/>
                    <count group_id="B2" value="35"/>
                    <count group_id="B3" value="70"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Health-related quality of life</title>
          <description>The reported values for the health-related quality of life are self-reported values using the VAS part of the two part EuroQoL EQ-5D-3L questionnaire. The scale ranges from 0 (worst quality) to 100 (best quality).</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="35"/>
                    <count group_id="B2" value="35"/>
                    <count group_id="B3" value="70"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="74.6" lower_limit="20" upper_limit="100"/>
                    <measurement group_id="B2" value="76.8" lower_limit="20" upper_limit="100"/>
                    <measurement group_id="B3" value="75.7" lower_limit="20" upper_limit="100"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Successful Removal of the Uterus Without Conversion to Another Technique</title>
        <description>Successful removal of the uterus without conversion to another technique with or without morcellation</description>
        <time_frame>Intraoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>vNOTES Hysterectomy</title>
            <description>vaginal Natural Orifice Transluminal Endoscopic Surgery
vNOTES hysterectomy: Surgical removal of the uterus by Natural Orifice Transluminal Endoscopic Surgery using a colpotomy</description>
          </group>
          <group group_id="O2">
            <title>LSC Hysterectomy</title>
            <description>Laparoscopic hysterectomy
LSC hysterectomy: Surgical removal of the uterus by transabdominal laparoscopy</description>
          </group>
        </group_list>
        <measure>
          <title>Successful Removal of the Uterus Without Conversion to Another Technique</title>
          <description>Successful removal of the uterus without conversion to another technique with or without morcellation</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="35"/>
                    <measurement group_id="O2" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>Our hypothesis was that women would accept a higher conversion rate of 15% for vNOTESbased on a telephone interview of 10 women treated by total vaginal NOTES hysterectomy. Women were asked to choose among ﬁve cut-off rates (5, 10, 15, 20 or 25%). Most women indicated 15%. We would conclude non-inferiority when the upper limit of the one-sided 95% conﬁdence interval for the difference in the proportions of women between both comparisons would be below 15%.</non_inferiority_desc>
            <p_value>0.0221</p_value>
            <p_value_desc>The Farrington-Manning test for non-inferiority was performed with 5% significance level and yielded P = 0.0221 in a sensitivity analysis assuming one conversion in the vNOTES and 0 conversions in the laparoscopy group.</p_value_desc>
            <method>Farrington-Manning</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Admission in Hospital for at Least One Night Observation</title>
        <description>The number of women admitted in-hospital for at least one night observation based on their own preference after discharge from the day care unit, as a dichotomous outcome. The decision to discharge or to admit to hospital for the night will be based solely on the choice of the woman to return home the same day or stay overnight.</description>
        <time_frame>Measured on the day of the surgical intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>vNOTES Hysterectomy</title>
            <description>vaginal Natural Orifice Transluminal Endoscopic Surgery
vNOTES hysterectomy: Surgical removal of the uterus by Natural Orifice Transluminal Endoscopic Surgery using a colpotomy</description>
          </group>
          <group group_id="O2">
            <title>LSC Hysterectomy</title>
            <description>Laparoscopic hysterectomy
LSC hysterectomy: Surgical removal of the uterus by transabdominal laparoscopy</description>
          </group>
        </group_list>
        <measure>
          <title>Admission in Hospital for at Least One Night Observation</title>
          <description>The number of women admitted in-hospital for at least one night observation based on their own preference after discharge from the day care unit, as a dichotomous outcome. The decision to discharge or to admit to hospital for the night will be based solely on the choice of the woman to return home the same day or stay overnight.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.007</p_value>
            <method>Fisher Exact</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>-0.34</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.56</ci_lower_limit>
            <ci_upper_limit>-0.13</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Pain Scores</title>
        <description>Postoperative pain scores, as an ordinal outcome, measured using a Visual Analogue Scale (VAS) twice daily (morning and evening) from day 1 till 7 selfreported by the participating women. VAS scores from 0 to 10 with 0 = no pain and 10= worst pain ever imaginable.</description>
        <time_frame>The first seven days after the surgical intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>vNOTES Hysterectomy</title>
            <description>vaginal Natural Orifice Transluminal Endoscopic Surgery
vNOTES hysterectomy: Surgical removal of the uterus by Natural Orifice Transluminal Endoscopic Surgery using a colpotomy</description>
          </group>
          <group group_id="O2">
            <title>LSC Hysterectomy</title>
            <description>Laparoscopic hysterectomy
LSC hysterectomy: Surgical removal of the uterus by transabdominal laparoscopy</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Pain Scores</title>
          <description>Postoperative pain scores, as an ordinal outcome, measured using a Visual Analogue Scale (VAS) twice daily (morning and evening) from day 1 till 7 selfreported by the participating women. VAS scores from 0 to 10 with 0 = no pain and 10= worst pain ever imaginable.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>mean pain VAS score day 1 morning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.629" lower_limit="2.877" upper_limit="4.380"/>
                    <measurement group_id="O2" value="4.200" lower_limit="3.449" upper_limit="4.951"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean pain VAS score day 1 evening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.486" lower_limit="2.815" upper_limit="4.157"/>
                    <measurement group_id="O2" value="4.456" lower_limit="3.783" upper_limit="5.129"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean pain VAS score day 2 morning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.486" lower_limit="1.876" upper_limit="3.096"/>
                    <measurement group_id="O2" value="3.543" lower_limit="2.933" upper_limit="4.153"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean pain VAS score day 2 evening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.514" lower_limit="1.947" upper_limit="3.082"/>
                    <measurement group_id="O2" value="3.343" lower_limit="2.775" upper_limit="3.910"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean pain VAS score day 3 morning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.800" lower_limit="1.261" upper_limit="2.339"/>
                    <measurement group_id="O2" value="2.800" lower_limit="2.261" upper_limit="3.339"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean pain VAS score day 3 evening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.857" lower_limit="1.335" upper_limit="2.379"/>
                    <measurement group_id="O2" value="2.914" lower_limit="2.392" upper_limit="3.436"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean pain VAS score day 4 morning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.257" lower_limit="0.746" upper_limit="1.769"/>
                    <measurement group_id="O2" value="2.286" lower_limit="1.774" upper_limit="2.797"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean pain VAS score day 4 evening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.371" lower_limit="0.867" upper_limit="1.876"/>
                    <measurement group_id="O2" value="2.457" lower_limit="1.952" upper_limit="2.962"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean pain VAS score day 5 morning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.143" lower_limit="0.643" upper_limit="1.642"/>
                    <measurement group_id="O2" value="1.914" lower_limit="1.415" upper_limit="2.414"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean pain VAS score day 5 evening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.057" lower_limit="0.562" upper_limit="1.553"/>
                    <measurement group_id="O2" value="2.086" lower_limit="1.590" upper_limit="2.581"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean pain VAS score day 6 morning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.914" lower_limit="0.421" upper_limit="1.407"/>
                    <measurement group_id="O2" value="1.914" lower_limit="1.421" upper_limit="2.407"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean pain VAS score day 6 evening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.086" lower_limit="0.591" upper_limit="1.580"/>
                    <measurement group_id="O2" value="2.000" lower_limit="1.505" upper_limit="2.495"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean pain VAS score day 7 morning</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.029" lower_limit="0.525" upper_limit="1.532"/>
                    <measurement group_id="O2" value="1.567" lower_limit="1.060" upper_limit="2.074"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>mean pain VAS score day 7 evening</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.819" lower_limit="0.290" upper_limit="1.348"/>
                    <measurement group_id="O2" value="1.693" lower_limit="1.153" upper_limit="2.233"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Use of Analgetic Drugs for Postoperative Pain</title>
        <description>Postoperative pain defined by the total amount of analgesics used as described in the standardized pain treatment protocol, as a continuous outcome.</description>
        <time_frame>The first week after the surgical intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>vNOTES Hysterectomy</title>
            <description>vaginal Natural Orifice Transluminal Endoscopic Surgery
vNOTES hysterectomy: Surgical removal of the uterus by Natural Orifice Transluminal Endoscopic Surgery using a colpotomy</description>
          </group>
          <group group_id="O2">
            <title>LSC Hysterectomy</title>
            <description>Laparoscopic hysterectomy
LSC hysterectomy: Surgical removal of the uterus by transabdominal laparoscopy</description>
          </group>
        </group_list>
        <measure>
          <title>The Use of Analgetic Drugs for Postoperative Pain</title>
          <description>Postoperative pain defined by the total amount of analgesics used as described in the standardized pain treatment protocol, as a continuous outcome.</description>
          <units>number of tablets</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.0" lower_limit="0" upper_limit="28"/>
                    <measurement group_id="O2" value="13.9" lower_limit="0" upper_limit="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.006</p_value>
            <method>Mann-Whitney U test</method>
            <method_desc>Two-sided test</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-5.9</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-10</ci_lower_limit>
            <ci_upper_limit>-1.8</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Infection</title>
        <description>Postoperative infection defined by lower abdominal pain with fever &gt; 38°C and positive clinical signs or laboratory findings, detected during the first six weeks of surgery, as a dichotomous outcome.</description>
        <time_frame>The first six weeks after the surgical intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>vNOTES Hysterectomy</title>
            <description>vaginal Natural Orifice Transluminal Endoscopic Surgery
vNOTES hysterectomy: Surgical removal of the uterus by Natural Orifice Transluminal Endoscopic Surgery using a colpotomy</description>
          </group>
          <group group_id="O2">
            <title>LSC Hysterectomy</title>
            <description>Laparoscopic hysterectomy
LSC hysterectomy: Surgical removal of the uterus by transabdominal laparoscopy</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Infection</title>
          <description>Postoperative infection defined by lower abdominal pain with fever &gt; 38°C and positive clinical signs or laboratory findings, detected during the first six weeks of surgery, as a dichotomous outcome.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>1.00</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Intra- Operative Complications</title>
        <description>Intra- operative complications according to the Clavien- Dindo classification detected during the first six weeks of surgery, as a dichotomous outcome</description>
        <time_frame>At the time of the surgical intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>vNOTES Hysterectomy</title>
            <description>vaginal Natural Orifice Transluminal Endoscopic Surgery
vNOTES hysterectomy: Surgical removal of the uterus by Natural Orifice Transluminal Endoscopic Surgery using a colpotomy</description>
          </group>
          <group group_id="O2">
            <title>LSC Hysterectomy</title>
            <description>Laparoscopic hysterectomy
LSC hysterectomy: Surgical removal of the uterus by transabdominal laparoscopy</description>
          </group>
        </group_list>
        <measure>
          <title>Intra- Operative Complications</title>
          <description>Intra- operative complications according to the Clavien- Dindo classification detected during the first six weeks of surgery, as a dichotomous outcome</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&gt; 0.05</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Postoperative Complications</title>
        <description>Postoperative complications detected during the first six weeks of surgery, as a dichotomous outcome</description>
        <time_frame>The first six weeks after the surgical intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>vNOTES Hysterectomy</title>
            <description>vaginal Natural Orifice Transluminal Endoscopic Surgery
vNOTES hysterectomy: Surgical removal of the uterus by Natural Orifice Transluminal Endoscopic Surgery using a colpotomy</description>
          </group>
          <group group_id="O2">
            <title>LSC Hysterectomy</title>
            <description>Laparoscopic hysterectomy
LSC hysterectomy: Surgical removal of the uterus by transabdominal laparoscopy</description>
          </group>
        </group_list>
        <measure>
          <title>Postoperative Complications</title>
          <description>Postoperative complications detected during the first six weeks of surgery, as a dichotomous outcome</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.009</p_value>
            <method>Fisher Exact</method>
            <param_type>Risk Difference (RD)</param_type>
            <param_value>-0.29</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.47</ci_lower_limit>
            <ci_upper_limit>-0.10</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospital Readmission</title>
        <description>The number of women readmitted to hospital within six weeks following surgery, as a dichotomous outcome.</description>
        <time_frame>The first six weeks after the surgical intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>vNOTES Hysterectomy</title>
            <description>vaginal Natural Orifice Transluminal Endoscopic Surgery
vNOTES hysterectomy: Surgical removal of the uterus by Natural Orifice Transluminal Endoscopic Surgery using a colpotomy</description>
          </group>
          <group group_id="O2">
            <title>LSC Hysterectomy</title>
            <description>Laparoscopic hysterectomy
LSC hysterectomy: Surgical removal of the uterus by transabdominal laparoscopy</description>
          </group>
        </group_list>
        <measure>
          <title>Hospital Readmission</title>
          <description>The number of women readmitted to hospital within six weeks following surgery, as a dichotomous outcome.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.106</p_value>
            <method>Fisher Exact</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Duration of the Surgical Intervention</title>
        <description>Duration of surgery measured as the time in minutes from the insertion of the bladder catheter to the end of vaginal/ abdominal wound closure, as a continuous outcome</description>
        <time_frame>Intraoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>vNOTES Hysterectomy</title>
            <description>vaginal Natural Orifice Transluminal Endoscopic Surgery
vNOTES hysterectomy: Surgical removal of the uterus by Natural Orifice Transluminal Endoscopic Surgery using a colpotomy</description>
          </group>
          <group group_id="O2">
            <title>LSC Hysterectomy</title>
            <description>Laparoscopic hysterectomy
LSC hysterectomy: Surgical removal of the uterus by transabdominal laparoscopy</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of the Surgical Intervention</title>
          <description>Duration of surgery measured as the time in minutes from the insertion of the bladder catheter to the end of vaginal/ abdominal wound closure, as a continuous outcome</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41.1" lower_limit="21.0" upper_limit="130.0"/>
                    <measurement group_id="O2" value="75.1" lower_limit="40.0" upper_limit="189.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt; 0.01</p_value>
            <method>Mann-Whitney U test</method>
            <param_type>Median Difference (Final Values)</param_type>
            <param_value>-34</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-46</ci_lower_limit>
            <ci_upper_limit>-22</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Vaginal Pain During Sexual Intercourse at Three Months</title>
        <description>Incidence of vaginal dyspareunia recorded by the participants at 3 months by self-reporting using a simple questionnaire.</description>
        <time_frame>At 3 months after the surgical intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>vNOTES Hysterectomy</title>
            <description>vaginal Natural Orifice Transluminal Endoscopic Surgery
vNOTES hysterectomy: Surgical removal of the uterus by Natural Orifice Transluminal Endoscopic Surgery using a colpotomy</description>
          </group>
          <group group_id="O2">
            <title>LSC Hysterectomy</title>
            <description>Laparoscopic hysterectomy
LSC hysterectomy: Surgical removal of the uterus by transabdominal laparoscopy</description>
          </group>
        </group_list>
        <measure>
          <title>Vaginal Pain During Sexual Intercourse at Three Months</title>
          <description>Incidence of vaginal dyspareunia recorded by the participants at 3 months by self-reporting using a simple questionnaire.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.7604</p_value>
            <p_value_desc>We tested a treatment arm by time interaction to study changes in differences for the outcomes during the follow-up period. In absence of such an interaction (p&gt;0.05 for the interaction term), the main effect of treatment was tested.</p_value_desc>
            <method>Arm by time interaction</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Vaginal Pain During Sexual Intercourse at Six Months</title>
        <description>Incidence of vaginal dyspareunia recorded by the participants at 6 months by self-reporting using a simple questionnaire</description>
        <time_frame>At 6 months after the surgical intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>vNOTES Hysterectomy</title>
            <description>vaginal Natural Orifice Transluminal Endoscopic Surgery
vNOTES hysterectomy: Surgical removal of the uterus by Natural Orifice Transluminal Endoscopic Surgery using a colpotomy</description>
          </group>
          <group group_id="O2">
            <title>LSC Hysterectomy</title>
            <description>Laparoscopic hysterectomy
LSC hysterectomy: Surgical removal of the uterus by transabdominal laparoscopy</description>
          </group>
        </group_list>
        <measure>
          <title>Vaginal Pain During Sexual Intercourse at Six Months</title>
          <description>Incidence of vaginal dyspareunia recorded by the participants at 6 months by self-reporting using a simple questionnaire</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.3071</p_value>
            <p_value_desc>We tested a treatment arm by time interaction to study changes in differences for the outcomes during the follow-up period. In absence of such an interaction (p&gt;0.05 for the interaction term), the main effect of treatment was tested.</p_value_desc>
            <method>Arm by time interaction</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pelvic Pain During Sexual Intercourse at Three Months</title>
        <description>Incidence of pelvic dyspareunia recorded by the participants at 3 months by self-reporting using a simple questionnaire.</description>
        <time_frame>At 3 months after the surgical intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>vNOTES Hysterectomy</title>
            <description>vaginal Natural Orifice Transluminal Endoscopic Surgery
vNOTES hysterectomy: Surgical removal of the uterus by Natural Orifice Transluminal Endoscopic Surgery using a colpotomy</description>
          </group>
          <group group_id="O2">
            <title>LSC Hysterectomy</title>
            <description>Laparoscopic hysterectomy
LSC hysterectomy: Surgical removal of the uterus by transabdominal laparoscopy</description>
          </group>
        </group_list>
        <measure>
          <title>Pelvic Pain During Sexual Intercourse at Three Months</title>
          <description>Incidence of pelvic dyspareunia recorded by the participants at 3 months by self-reporting using a simple questionnaire.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.4541</p_value>
            <p_value_desc>We tested a treatment arm by time interaction to study changes in differences for the outcomes during the follow-up period. In absence of such an interaction (p&gt;0.05 for the interaction term), the main effect of treatment was tested.</p_value_desc>
            <method>Arm by time interaction</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Pelvic Pain During Sexual Intercourse at Six Months</title>
        <description>Incidence of pelvic dyspareunia recorded by the participants at 6 months by self-reporting using a simple questionnaire.</description>
        <time_frame>At 6 months after the surgical intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>vNOTES Hysterectomy</title>
            <description>vaginal Natural Orifice Transluminal Endoscopic Surgery
vNOTES hysterectomy: Surgical removal of the uterus by Natural Orifice Transluminal Endoscopic Surgery using a colpotomy</description>
          </group>
          <group group_id="O2">
            <title>LSC Hysterectomy</title>
            <description>Laparoscopic hysterectomy
LSC hysterectomy: Surgical removal of the uterus by transabdominal laparoscopy</description>
          </group>
        </group_list>
        <measure>
          <title>Pelvic Pain During Sexual Intercourse at Six Months</title>
          <description>Incidence of pelvic dyspareunia recorded by the participants at 6 months by self-reporting using a simple questionnaire.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.4514</p_value>
            <p_value_desc>We tested a treatment arm by time interaction to study changes in differences for the outcomes during the follow-up period. In absence of such an interaction (p&gt;0.05 for the interaction term), the main effect of treatment was tested.</p_value_desc>
            <method>Arm by time interaction</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Health-related Quality of Life at Three Months</title>
        <description>Health-related quality of life at 3 months by self-reporting the EQ-5D scale.The reported values for the health-related quality of life are self-reported values using the VAS part of the two part EQ-5D-3L questionnaire. The scale ranges from 0 (worst quality) to 100 (best quality).</description>
        <time_frame>At 3 months after the surgical intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>vNOTES Hysterectomy</title>
            <description>vaginal Natural Orifice Transluminal Endoscopic Surgery
vNOTES hysterectomy: Surgical removal of the uterus by Natural Orifice Transluminal Endoscopic Surgery using a colpotomy</description>
          </group>
          <group group_id="O2">
            <title>LSC Hysterectomy</title>
            <description>Laparoscopic hysterectomy
LSC hysterectomy: Surgical removal of the uterus by transabdominal laparoscopy</description>
          </group>
        </group_list>
        <measure>
          <title>Health-related Quality of Life at Three Months</title>
          <description>Health-related quality of life at 3 months by self-reporting the EQ-5D scale.The reported values for the health-related quality of life are self-reported values using the VAS part of the two part EQ-5D-3L questionnaire. The scale ranges from 0 (worst quality) to 100 (best quality).</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83.8" lower_limit="40.0" upper_limit="100.0"/>
                    <measurement group_id="O2" value="79.6" lower_limit="20.0" upper_limit="100.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.3473</p_value>
            <p_value_desc>We tested a treatment arm by time interaction to study changes in differences for the outcomes during the follow-up period. In absence of such an interaction (p&gt;0.05 for the interaction term), the main effect of treatment was tested.</p_value_desc>
            <method>Arm by time interaction</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Health-related Quality of Life at Six Months</title>
        <description>Health-related quality of life at 6 months by self-reporting the EQ-5D scale. The reported values for the health-related quality of life are self-reported values using the VAS part of the two part EQ-5D-3L questionnaire. The scale ranges from 0 (worst quality) to 100 (best quality).</description>
        <time_frame>At 6 months after the surgical intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>vNOTES Hysterectomy</title>
            <description>vaginal Natural Orifice Transluminal Endoscopic Surgery
vNOTES hysterectomy: Surgical removal of the uterus by Natural Orifice Transluminal Endoscopic Surgery using a colpotomy</description>
          </group>
          <group group_id="O2">
            <title>LSC Hysterectomy</title>
            <description>Laparoscopic hysterectomy
LSC hysterectomy: Surgical removal of the uterus by transabdominal laparoscopy</description>
          </group>
        </group_list>
        <measure>
          <title>Health-related Quality of Life at Six Months</title>
          <description>Health-related quality of life at 6 months by self-reporting the EQ-5D scale. The reported values for the health-related quality of life are self-reported values using the VAS part of the two part EQ-5D-3L questionnaire. The scale ranges from 0 (worst quality) to 100 (best quality).</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.8" lower_limit="60.0" upper_limit="100.0"/>
                    <measurement group_id="O2" value="86.6" lower_limit="65.0" upper_limit="100.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>We tested a treatment arm by time interaction to study changes in differences for the outcomes during the follow-up period. In absence of such an interaction (p&gt;0.05 for the interaction term), the main effect of treatment was tested.</non_inferiority_desc>
            <p_value>0.3473</p_value>
            <p_value_desc>We tested a treatment arm by time interaction to study changes in differences for the outcomes during the follow-up period. In absence of such an interaction (p&gt;0.05 for the interaction term), the main effect of treatment was tested.</p_value_desc>
            <method>Arm by time interaction</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Sexual Well Being</title>
        <description>Sexual wellbeing at baseline, at 3 and 6 months by self-reporting using the SSFS (Short Sexual Function Scale). The SSFS is a questionnaire of 7 open ended questions on sexual wellbeing.</description>
        <time_frame>At baseline, 3 months and 6 months after the surgical intervention</time_frame>
        <posting_date>09/2020</posting_date>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Direct Costs</title>
        <description>Calculating the comparative direct costs in USD of both techniques up to 6 weeks after the surgical intervention</description>
        <time_frame>Up to 6 weeks postoperative</time_frame>
        <group_list>
          <group group_id="O1">
            <title>vNOTES Hysterectomy</title>
            <description>vaginal Natural Orifice Transluminal Endoscopic Surgery
vNOTES hysterectomy: Surgical removal of the uterus by Natural Orifice Transluminal Endoscopic Surgery using a colpotomy</description>
          </group>
          <group group_id="O2">
            <title>LSC Hysterectomy</title>
            <description>Laparoscopic hysterectomy
LSC hysterectomy: Surgical removal of the uterus by transabdominal laparoscopy</description>
          </group>
        </group_list>
        <measure>
          <title>Direct Costs</title>
          <description>Calculating the comparative direct costs in USD of both techniques up to 6 weeks after the surgical intervention</description>
          <units>USD</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="35"/>
                <count group_id="O2" value="35"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3452.2" lower_limit="2404.6" upper_limit="4897.1"/>
                    <measurement group_id="O2" value="3933.6" lower_limit="2120.6" upper_limit="6776.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.110</p_value>
            <method>Mann-Whitney U test</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-555.8</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1,044</ci_lower_limit>
            <ci_upper_limit>36</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 months</time_frame>
      <desc>Intra- or postoperative complications</desc>
      <group_list>
        <group group_id="E1">
          <title>vNOTES Hysterectomy</title>
          <description>vaginal Natural Orifice Transluminal Endoscopic Surgery
vNOTES hysterectomy: Surgical removal of the uterus by Natural Orifice Transluminal Endoscopic Surgery using a colpotomy</description>
        </group>
        <group group_id="E2">
          <title>LSC Hysterectomy</title>
          <description>Laparoscopic hysterectomy
LSC hysterectomy: Surgical removal of the uterus by transabdominal laparoscopy</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="35"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="35"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>vesicovaginal fistula</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="35"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Pulmonary embolus</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="35"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="35"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="35"/>
                <counts group_id="E2" subjects_affected="11" subjects_at_risk="35"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Blood transfusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="35"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="35"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="35"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="35"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Data on postoperative pain scores are available in figure 2 in Baekelandt JF, et al. BJOG 2019;126:105–113.
Dat on sexual well-being will be analysed at a later date.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr Jan Baekelandt</name_or_title>
      <organization>Imelda ziekenhuis Bonheiden</organization>
      <phone>+ 32 15 505208</phone>
      <email>jan.baekelandt@imelda.be</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

